IBEC reaches the market

We’re proud that some of our technologies and discoveries have become a reality and are now on the market.

It’s been a pleasure to collaborate with companies to develop these products and bring them to society. Our market-driven approach combines with the know-how of companies to develop final prototypes, taken them through the pre-clinical and clinical requirements stages when required, and successful navigate the regulatory pathways to obtain commercial authorization to finally make things a reality.

Below are some of the examples which are a reality today, but we are working on other, still confidential, products that we hope will reach the market and offer a solution for  patients soon.


NEDxA, commercialized by Genomica

The Nano Electronic Diagnostic Array (NEDxA) is the result of the Joint Research Unit between IBEC’s Nanobioengineering group, led by Josep Samitier, and Genomica S.A.U. (Grupo Zeltia), the leading Spanish company in molecular diagnostics.

NEDxA-HPV is a new in vitro diagnostics device for Human Papillomavirus (HPV) testing, a new product that carries out analysis to detect HPV in a cheap, quick and convenient desktop device.

This is a milestone in the history of Genomica that transcends for the first time from its well-established CLART technology to present a revolutionary molecular diagnostics device. IBEC and Genomica will continue this fruitful collaboration to bring more new products in the market.

Designed, developed and manufactured to perform complex laboratory analysis in any testing environment, NEDxA integrates all the processes in a single device, providing a fast, easy, specific and sensitive platform for molecular diagnostics. is used to detect and genotype all high risk human Papilomavirus subtypes. NEDxA reduces the workflow to just one step delivering a true walk-away solution suitable for non-specialized personnel. Using test-specific disposable cartridges, NEDxA is a closed system which does not require any sample preparation, set up or calibration procedure.


FlexInLight robotic light system, commercialized by Telstar

Lighting in hospital operating theatres plays an important role in any surgical procedure.

http://www.upc.edu/saladepremsa/al-dia/mes-noticies/robotic-lighting-system-gives-surgeons-clearer-view-in-operating-theatres/Telstar-Smart-Light-System-mar16-web.jpgOperating lights must be directed toward various points at different intensities to provide an optimal view. They must also adapt to the movements of the surgical team and of the tools used in each operation. “An operating theatre is a very tricky space to light,” says Prof. Alícia Casals. “You have various people moving around the patient, equipment suspended from the ceiling, moments when a very powerful light needs to be directed at a specific area, and other points when the lighting must be dimmed and come from a different direction to avoid having the surgeon cast a shadow.”

IBEC’s former Robotics group led by Prof. Casals, Parc Taulí and the companies Telstar and Luxiona have developed an innovative smart lighting system for operating theatres. It consists of an overhead light and two oblique light sources. Thanks to the way they are positioned, the lights eliminate shadows in the working area while also minimising infrared and ultraviolet radiation. Other advantages over traditional lamps are a reduction in the risk of hospital infections, higher energy efficiency, and a significant improvement in working conditions for medical staff.

The  system could have additional uses in spaces where light and airflow need to be controlled, including delivery rooms and other facilities, and even non-medical settings. Equipped with LED bulbs, the new system allows users to efficiently control the direction and intensity of the light beam projected onto the surgical field as required during an operation. The product is currently in the market.

Ficosa S.A.

Joining forces to save lives


A collaboration between IBEC, the UB and industry partner Ficosa resulted in a new technology to combat dozing off when driving.

The drowsiness alerter, Somnoalert®, is a smart phone application that uses inertial sensors and GPS data to detect movements that are characteristic of nodding off at the wheel, such as deviation from the driving lane, or sudden corrections. A later prototype also incorporates biomedical sensors to analyze respiration data.

The patented software is the result of a collaborative project between IBEC’s Signal and Information Processing for Sensing Systems group led by Santiago Marco, the UB’s Department of Electronic Engineering and Ficosa, a Barcelona-based multinational that researches, develops, produces and commercializes automobile systems and parts.

“One of the main causes of car accidents is drowsiness, especially on long highway trips,” explains Santiago. “Most monitoring systems developed in the last few years have been integrated systems that need to be connected to the car’s system. Our device combines our group’s expertise in sensors and biological data analysis with Ficosa’s vehicle know-how, and is completely portable.”

“Accidents related with drowsiness have a very high social and economical impact, that the key automotive industry players are facing as a whole, in order to reduce current accident statistics,” adds Alan Montesi, who is responsible for the project at Ficosa.

The technology was first presented at the GSMA World Mobile Congress in Barcelona, the industry’s biggest conference, in 2013.